交易中 10-18 10:36:40 美东时间
-0.160
-6.81%
Inhibikase Therapeutics ( ($IKT) ) has shared an update. Inhibikase Therapeutic...
10-11 05:57
-SEC Filing
10-11 04:22
北京时间2024年10月10日02时11分,Ginkgo Bioworks Holdings, Inc.(DNA.us)股票出现波动,股价急速下跌5.04%。截...
10-10 02:11
北京时间2024年10月10日00时12分,康乃德生物(CNTB.us)股票出现异动,股价急速下挫5.47%。截至发稿,该股报1.21美元/股,成交量777股...
10-10 00:12
Inhibikase Therapeutics (NASDAQ:IKT) on Wednesday has announced the pricing of an approximately $110M private offering, led by new investor Soleus Capital. The pharma company intends to use the net pr...
10-09 22:16
HC Wainwright & Co. analyst Edward White maintains Inhibikase Therapeutics (NASDAQ:IKT) with a Buy and lowers the price target from $23 to $15.
08-16 17:39
Unity Software(U.US) reported fourth-quarter financial results after the market...
08-16 17:35
Inhibikase Therapeutics - Qtrly Shr Loss $0.66
08-15 04:28
Inhibikase Therapeutics (NASDAQ:IKT) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.67) by 1.49 percent. This is a 29.79 percent increase over losses of $(0.94) per share
08-15 04:26
Inhibikase Therapeutics Reports Second Quarter Financial Results and Highlights...
08-15 04:25